CVS Health (NYSE:CVS) Earns Neutral Rating from Cantor Fitzgerald

Cantor Fitzgerald restated their neutral rating on shares of CVS Health (NYSE:CVS) in a research note issued to investors on Monday morning, Benzinga reports. They currently have a $62.00 price objective on the pharmacy operator’s stock.

A number of other research firms have also recently commented on CVS. Barclays decreased their target price on shares of CVS Health from $65.00 to $63.00 and set an equal weight rating on the stock in a research report on Thursday, August 8th. Evercore ISI dropped their target price on shares of CVS Health from $65.00 to $62.00 and set an outperform rating for the company in a report on Thursday, August 8th. JPMorgan Chase & Co. decreased their price target on CVS Health from $101.00 to $86.00 and set an overweight rating on the stock in a research note on Thursday, May 30th. Wells Fargo & Company lifted their target price on CVS Health from $60.00 to $61.00 and gave the company an equal weight rating in a research report on Monday, August 12th. Finally, Baird R W upgraded shares of CVS Health to a hold rating in a research note on Thursday, May 30th. Eleven research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of Moderate Buy and a consensus price target of $72.10.

CVS Health Stock Performance

Shares of CVS Health stock opened at $58.42 on Monday. CVS Health has a one year low of $52.77 and a one year high of $83.25. The company has a market cap of $73.34 billion, a price-to-earnings ratio of 10.27, a PEG ratio of 0.79 and a beta of 0.53. The business’s 50 day moving average price is $58.33 and its 200 day moving average price is $62.74. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.10. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The business had revenue of $91.23 billion during the quarter, compared to analysts’ expectations of $91.41 billion. During the same quarter in the prior year, the company posted $2.21 EPS. The business’s revenue for the quarter was up 2.6% on a year-over-year basis. On average, research analysts predict that CVS Health will post 6.51 EPS for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, August 1st. Investors of record on Monday, July 22nd were paid a dividend of $0.665 per share. The ex-dividend date was Monday, July 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 4.55%. CVS Health’s dividend payout ratio is presently 46.75%.

Institutional Trading of CVS Health

Large investors have recently bought and sold shares of the business. Ables Iannone Moore & Associates Inc. purchased a new stake in CVS Health during the 4th quarter valued at approximately $32,000. First Community Trust NA increased its holdings in shares of CVS Health by 116.2% in the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after purchasing an additional 302 shares in the last quarter. Creekmur Asset Management LLC acquired a new stake in shares of CVS Health in the fourth quarter valued at about $34,000. Steph & Co. boosted its holdings in CVS Health by 192.0% during the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after buying an additional 288 shares in the last quarter. Finally, ORG Partners LLC grew its position in CVS Health by 11,840.0% during the second quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock worth $35,000 after buying an additional 592 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.